Back
America Movil SAB de CV Vs. Nektar Therapeutics Industry Stock Comparison
Buy
51
AMX
America Movil SAB de CV
Last Price:
$18.99
Seasonality Move:
-0.28%
Buy
51
NKTR
Nektar Therapeutics
Last Price:
$21.61
Seasonality Move:
-1.52%
Buy
51
America Movil SAB de CV (AMX)
is a Buy
Is America Movil SAB de CV a Buy, Sell or Hold?
-
The current America Movil SAB de CV [AMX] share price is $18.17. The Score for AMX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
AMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $22.45. The Score for NKTR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMX Stock Price Chart
What is America Movil SAB de CV's stock price today?
-
The America Movil SAB de CV share price today is $18.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMX is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $22.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
AMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 58.45 | Buy |
| Chaikin Money Flow: | -2361953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.41 - 18.23) | Buy |
| Bollinger Bands (100): | (15.27 - 18.03) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.17 | Buy |
| Relative Strength Index (14 RSI): | 50.31 | Buy |
| Chaikin Money Flow: | -112923 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.78 - 25.16) | Sell |
| Bollinger Bands (100): | (7.96 - 21.44) | Buy |
AMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.12 | Buy |
| 20-day SMA: | 17.79 | Buy |
| 50-day SMA: | 17.53 | Buy |
| 200-day SMA: | 15.76 | Buy |
| 8-day EMA: | 18.07 | Buy |
| 20-day EMA: | 17.9 | Buy |
| 50-day EMA: | 17.51 | Buy |
| 200-day EMA: | 16.53 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.69 | Sell |
| 20-day SMA: | 23.97 | Sell |
| 50-day SMA: | 18.95 | Buy |
| 200-day SMA: | 14.98 | Buy |
| 8-day EMA: | 18.7 | Buy |
| 20-day EMA: | 11.37 | Buy |
| 50-day EMA: | 5.51 | Buy |
| 200-day EMA: | 1.53 | Buy |
America Movil SAB de CV Earnings Growth & AMX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.08 per share, an increase this year of $0.84 per share, and an increase next year of $0.13 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.99 per share, and a decrease next year of $1.16 per share.
America Movil SAB de CV Technical Analysis
| Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||